Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Massimiliano Buoli, Alice Caldiroli & Marta Serati. (2017) Pharmacokinetic evaluation of pregabalin for the treatment of generalized anxiety disorder. Expert Opinion on Drug Metabolism & Toxicology 13:3, pages 351-359.
Read now
Read now
Sabine M. Allida, Sally C. Inglis, Patricia M. Davidson, Christopher S. Hayward, Sajad Shehab & Phillip J. Newton. (2016) A survey of views and opinions of health professionals managing thirst in chronic heart failure. Contemporary Nurse 52:2-3, pages 244-252.
Read now
Read now
Borwin Bandelow & Sophie Michaelis. (2015) Epidemiology of anxiety disorders in the 21st century. Dialogues in Clinical Neuroscience 17:3, pages 327-335.
Read now
Read now
Stefano Pallanti, Tommaso Tofani, Matteo Zanardelli, Lorenzo Di Cesare Mannelli & Carla Ghelardini. (2014) BDNF and ARTEMIN are increased in drug-naïve non-depressed GAD patients: Preliminary data. International Journal of Psychiatry in Clinical Practice 18:4, pages 255-260.
Read now
Read now
David S Baldwin, Khalil Ajel, Vasilios G Masdrakis, Magda Nowak & Rizwan Rafiq. (2013) Pregabalin for the treatment of generalized anxiety disorder: an update. Neuropsychiatric Disease and Treatment 9, pages 883-892.
Read now
Read now
Articles from other publishers (43)
David S. Baldwin & Vasilios Masdrakis. (2023) Non-prescribed use of gabapentinoids. Clinics in Integrated Care 21, pages 100164.
Crossref
Crossref
Boris Karpov, Jari Olavi Lipsanen, Ville Ritola, Tom Rosenström, Suoma Saarni, Satu Pihlaja, Jan-Henry Stenberg, Paula Laizane & Grigori Joffe. (2023) The Overall Anxiety Severity and Impairment Scale as an Outcome Measure in Internet-Delivered Cognitive Behavioral Therapy for Anxiety Disorders: Observational Study. Journal of Medical Internet Research 25, pages e45362.
Crossref
Crossref
Pravitha Madathodiyil Ravunnikutty, Latha Krishnamurthy, Meena Kolar Sreedhara Murthy, Aruna R. M. Kapanee, Santosh K. ChaturvediDeepika Saini. (2022) Perception on Anxiety among Adolescents and Mental Health Professionals and Development of Comic Strip. Indian Journal of Psychological Medicine 45:3, pages 271-276.
Crossref
Crossref
Seung Yeon Baik & Michelle G. Newman. 2023. Encyclopedia of Mental Health. Encyclopedia of Mental Health
66
73
.
Soumya Choudhary, Nikita Thomas, Sultan Alshamrani, Girish Srinivasan, Janine Ellenberger, Usman Nawaz & Roy Cohen. (2022) A Machine Learning Approach for Continuous Mining of Nonidentifiable Smartphone Data to Create a Novel Digital Biomarker Detecting Generalized Anxiety Disorder: Prospective Cohort Study. JMIR Medical Informatics 10:8, pages e38943.
Crossref
Crossref
Sohrab Amiri. (2022) Global prevalence of anxiety and PTSD in immigrants: a systematic review and meta-analysisGlobale Prävalenz von Angst und PTSD bei Migranten: systematischer Review und Metaanalyse. neuropsychiatrie 36:2, pages 69-88.
Crossref
Crossref
David S. Baldwin. (2021) Clinical management of withdrawal from benzodiazepine anxiolytic and hypnotic medications. Addiction 117:5, pages 1472-1482.
Crossref
Crossref
Renan P. Monteiro, Bruna S. Nascimento, Tatiana Medeiros Costa Monteiro, Phillip Dyamond Gomes da Silva & Ana Júlia Cândida Ferreira. (2020) Psychometric Evidence of the 7-Item Generalized Anxiety Disorder Questionnaire in Brazil. International Journal of Mental Health and Addiction 20:2, pages 1023-1034.
Crossref
Crossref
Nazanin Alavi & Callum Stephenson. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
2083
2097
.
Andrey A. Ivashchenko, Margarita A. Morozova, Natalia V. Vostokova, Allan G. Beniashvily, Olga A. Bukhanovskaya, Denis S. Burminskiy, Alina N. Egorova, Lubov Y. Gluskina, Dmitriy S. Gorchakov, Ruben N. Karapetian, Lala N. Kasimova, Dmitry V. Kravchenko, Taissia A. Lepilkina, Elena A. Merkulova, Oleg D. Mitkin, Nataliya A. Penchul, Sergey S. Potanin, George E. Rupchev & Alexandre V. Ivachtchenko. (2021) Safety and efficacy of aviandr in patients with generalized anxiety disorder: A multicenter, randomized, double-blind, placebo-controlled, dose-finding, pilot study. Journal of Psychiatric Research 143, pages 436-444.
Crossref
Crossref
Nicola R Hemmings, Jamie M Kawadler, Rachel Whatmough, Sonia Ponzo, Alessio Rossi, Davide Morelli, Geoffrey Bird & David Plans. (2021) Development and Feasibility of a Digital Acceptance and Commitment Therapy–Based Intervention for Generalized Anxiety Disorder: Pilot Acceptability Study. JMIR Formative Research 5:2, pages e21737.
Crossref
Crossref
Nazanin Alavi & Callum Stephenson. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
16
.
Andras N. Zsido, Szidalisz A. Teleki, Krisztina Csokasi, Sandor Rozsa & Szabolcs A. Bandi. (2020) Development of the short version of the spielberger state—trait anxiety inventory. Psychiatry Research 291, pages 113223.
Crossref
Crossref
David S. Baldwin. 2020. Generalized Anxiety Disorder and Worrying. Generalized Anxiety Disorder and Worrying
297
318
.
Giovanni A. Fava. (2020) May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance. Therapeutic Advances in Psychopharmacology 10, pages 204512532097032.
Crossref
Crossref
Milica Stanojevic & Dragan Panic. (2019) Treatment of Anxiety Disorders - The Role of Pharmacists. Serbian Journal of Experimental and Clinical Research 0:0.
Crossref
Crossref
Vera De Carlo, Benedetta Grancini, Matteo Vismara, Beatrice Benatti, Chiara Arici, Laura Cremaschi, Giovanna Cirnigliaro, Luca Degoni, Lucio Oldani, Carlotta Palazzo, Ira D. Glick, Caterina Viganò & Bernardo Dell'Osso. (2019) Exploring characteristics associated with first benzodiazepine prescription in patients with affective disorders and related diagnoses. Human Psychopharmacology: Clinical and Experimental 34:3, pages e2695.
Crossref
Crossref
Henrique D. P. dos Santos, Ana Helena D. P. S. Ulbrich, Vinicius Woloszyn & Renata Vieira. (2019) DDC-Outlier: Preventing Medication Errors Using Unsupervised Learning. IEEE Journal of Biomedical and Health Informatics 23:2, pages 874-881.
Crossref
Crossref
David S. Baldwin & Ayman Abou-Aisha. 2019. Translational Medicine in CNS Drug Development. Translational Medicine in CNS Drug Development
363
374
.
Margarita Sáenz-Herrero, Álvar Peña-Rotella, Ane Eizaguirre-Garcia & Karim Haidar. 2019. Psychopathology in Women. Psychopathology in Women
639
669
.
Gavin Andrews, Caroline Bell, Philip Boyce, Christopher Gale, Lisa Lampe, Omar Marwat, Ronald Rapee & Gregory Wilkins. (2018) Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder. Australian & New Zealand Journal of Psychiatry 52:12, pages 1109-1172.
Crossref
Crossref
Benedetta Grancini, Vera De Carlo, Mariacarlotta Palazzo, Matteo Vismara, Chiara Arici, Laura Cremaschi, Beatrice Benatti, A. Carlo Altamura & Bernardo Dell’Osso. (2018) Does initial use of benzodiazepines delay an adequate pharmacological treatment? A multicentre analysis in patients with psychotic and affective disorders. International Clinical Psychopharmacology 33:3, pages 140-146.
Crossref
Crossref
Giuseppe Guaiana, Corrado Barbui & Russlan Abouhassan. (2018) Antidepressants versus placebo for generalised anxiety disorder (GAD). Cochrane Database of Systematic Reviews.
Crossref
Crossref
Giovanni A. Fava. 2018. Well-Being Therapy. la Psychothérapie du Bien-être. Well-Being Therapy. la Psychothérapie du Bien-être
101
107
.
Milan Latas, Goran Trajković, Dimitar Bonevski, Andromahi Naumovska, Dušanka Vučinić Latas, Zoran Bukumirić & Vladan Starčević. (2018) Psychiatrists' treatment preferences for generalized anxiety disorder. Human Psychopharmacology: Clinical and Experimental 33:1, pages e2643.
Crossref
Crossref
David S. Baldwin, Ruihua Hou, Robert Gordon, Nathan T. M. Huneke & Matthew Garner. (2017) Pharmacotherapy in Generalized Anxiety Disorder: Novel Experimental Medicine Models and Emerging Drug Targets. CNS Drugs 31:4, pages 307-317.
Crossref
Crossref
John R Keefe, Jun J Mao, Irene Soeller, Qing S Li & Jay D Amsterdam. (2016) Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder. Phytomedicine 23:14, pages 1699-1705.
Crossref
Crossref
Beatrice Benatti, Giulia Camuri, Bernardo Dell’Osso, Laura Cremaschi, Ester Sembira, Carlotta Palazzo, Lucio Oldani, Cristina Dobrea, Chiara Arici, Diego Primavera, Bernardo Carpiniello, Filippo Castellano, Giuseppe Carrà, Massimo Clerici, David S. Baldwin & Alfredo Carlo Altamura. (2016) Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?. International Clinical Psychopharmacology 31:6, pages 347-352.
Crossref
Crossref
G. Guaiana & C. Barbui. (2016) Discontinuing benzodiazepines: best practices. Epidemiology and Psychiatric Sciences 25:3, pages 214-216.
Crossref
Crossref
Naoki Yoshinaga, Satoshi Matsuki, Tomihisa Niitsu, Yasunori Sato, Mari Tanaka, Hanae Ibuki, Rieko Takanashi, Keiko Ohshiro, Fumiyo Ohshima, Kenichi Asano, Osamu Kobori, Kensuke Yoshimura, Yoshiyuki Hirano, Kyoko Sawaguchi, Masaya Koshizaka, Hideki Hanaoka, Akiko Nakagawa, Michiko Nakazato, Masaomi Iyo & Eiji Shimizu. (2016) Cognitive Behavioral Therapy for Patients with Social Anxiety Disorder Who Remain Symptomatic following Antidepressant Treatment: A Randomized, Assessor-Blinded, Controlled Trial. Psychotherapy and Psychosomatics 85:4, pages 208-217.
Crossref
Crossref
A. A. Pribytkov, N. B. Panova, Yu. V. Popova & K. G. Emtsov. (2015) Efficacy of Agomelatine in Depressive Disorders with Anxiety. Neuroscience and Behavioral Physiology 45:4, pages 393-397.
Crossref
Crossref
Daniele Zullino, Anne Chatton, Emmanuelle Fresard, Miroslava Stankovic, Guido Bondolfi, François Borgeat & Yasser Khazaal. (2014) Venlafaxine Versus Applied Relaxation for Generalized Anxiety Disorder: A Randomized Controlled Study on Clinical and Electrophysiological Outcomes. Psychiatric Quarterly 86:1, pages 69-82.
Crossref
Crossref
Mohammad Reza Fayyazi Bordbar, Farhad Faridhosseini & Ali Saghebi. 2015. Basic and Clinical Toxicology of Mustard Compounds. Basic and Clinical Toxicology of Mustard Compounds
291
315
.
Karla J. Alaka, William Noble, Angel Montejo, Héctor Dueñas, Autar Munshi, Jeffrey R. Strawn, Alan Lenox‐Smith, Jonna Ahl, Leszek Bidzan, Brita Dorn & Susan Ball. (2014) Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double‐blind, placebo‐controlled trial. International Journal of Geriatric Psychiatry 29:9, pages 978-986.
Crossref
Crossref
Siegfried Kasper, Celso Iglesias-García, Edward Schweizer, Jacquelyn Wilson, Sarah DuBrava, Rita Prieto, Verne W. Pitman & Lloyd Knapp. (2013) Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder. The International Journal of Neuropsychopharmacology 17:05, pages 685-695.
Crossref
Crossref
Giovanni A. Fava. (2014) Rational Use of Antidepressant Drugs. Psychotherapy and Psychosomatics 83:4, pages 197-204.
Crossref
Crossref
Philippe Goffaux, Guillaume Léonard & Mylène Lévesque. 2014. Mental Health and Pain. Mental Health and Pain
33
45
.
Inmaculada Failde, Maria Dueñas, Luis Agüera-Ortíz, Jorge A Cervilla, Ana Gonzalez-Pinto & Juan A Mico. (2013) Factors associated with chronic pain in patients with bipolar depression: a cross-sectional study. BMC Psychiatry 13:1.
Crossref
Crossref
Vincenzo Micale, Vincenzo Di Marzo, Alexandra Sulcova, Carsten T. Wotjak & Filippo Drago. (2013) Endocannabinoid system and mood disorders: Priming a target for new therapies. Pharmacology & Therapeutics 138:1, pages 18-37.
Crossref
Crossref
Sonja M. Wojcik, Martesa Tantra, Beata Stepniak, Kwun-nok M. Man, Katja Müller-Ribbe, Martin Begemann, Anes Ju, Sergi Papiol, Anja Ronnenberg, Artem Gurvich, Yong Shin, Iris Augustin, Nils Brose & Hannelore Ehrenreich. (2013) Genetic Markers of a Munc13 Protein Family Member, BAIAP3, Are Gender Specifically Associated with Anxiety and Benzodiazepine Abuse in Mice and Humans. Molecular Medicine 19:1, pages 135-148.
Crossref
Crossref
Serge Marchand, Djea Saravane & Isabelle GaumondPh. Goffaux, G. Léonard & M. Lévesque. 2013. Santé mentale et douleur. Santé mentale et douleur
37
52
.
David S. Baldwin & Bilal Talat. (2012) Should benzodiazepines still have a role in treating patients with anxiety disorders?. Human Psychopharmacology: Clinical and Experimental 27:3, pages 237-238.
Crossref
Crossref
Christer Allgulander. (2012) Generalized Anxiety Disorder: A Review of Recent Findings. Journal of Experimental & Clinical Medicine 4:2, pages 88-91.
Crossref
Crossref